Salman Al-Mahmood
Keine laufenden Positionen mehr
Karriereverlauf von Salman Al-Mahmood
Ehemalige bekannte Positionen von Salman Al-Mahmood
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gene Signal International SA
 Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | 23.09.2010 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 23.09.2010 | - | |
| Gründer | 23.09.2010 | - |
Ausbildung von Salman Al-Mahmood
| Université Nancy II | Doctorate Degree |
Statistik
International
| Schweiz | 2 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Börse
- Insiders
- Salman Al-Mahmood
- Erfahrung
